Literature DB >> 24102565

Huntington disease and Huntington disease-like in a case series from Brazil.

R M Castilhos1, A F D Souza, G V Furtado, T C Gheno, A L Silva, F R Vargas, M-A F D Lima, O Barsottini, J L Pedroso, C Godeiro, D Salarini, E T Pereira, K Lin, M-B Toralles, J A M Saute, C R Rieder, M Quintas, J Sequeiros, I Alonso, M L Saraiva-Pereira, L B Jardim.   

Abstract

The aim of this study was to identify the relative frequency of Huntington's disease (HD) and HD-like (HDL) disorders HDL1, HDL2, spinocerebellar ataxia type 2 (SCA2), SCA17, dentatorubral-pallidoluysian degeneration (DRPLA), benign hereditary chorea, neuroferritinopathy and chorea-acanthocytosis (CHAC), in a series of Brazilian families. Patients were recruited in seven centers if they or their relatives presented at least chorea, besides other findings. Molecular studies of HTT, ATXN2, TBP, ATN1, JPH3, FTL, NKX2-1/TITF1 and VPS13A genes were performed. A total of 104 families were ascertained from 2001 to 2012: 71 families from South, 25 from Southeast and 8 from Northeast Brazil. There were 93 HD, 4 HDL2 and 1 SCA2 families. Eleven of 104 index cases did not have a family history: 10 with HD. Clinical characteristics were similar between HD and non-HD cases. In HD, the median expanded (CAG)n (range) was 44 (40-81) units; R(2) between expanded HTT and age-at-onset (AO) was 0.55 (p=0.0001, Pearson). HDL2 was found in Rio de Janeiro (2 of 9 families) and Rio Grande do Sul states (2 of 68 families). We detected HD in 89.4%, HDL2 in 3.8% and SCA2 in 1% of 104 Brazilian families. There were no cases of HDL1, SCA17, DRPLA, neuroferritinopathy, benign hereditary chorea or CHAC. Only six families (5.8%) remained without diagnosis.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Brazil; DRPLA; HD; HD-like; HDL1; HDL2; Huntington disease; Huntington disease-like 2; SCA2; benign hereditary chorea; chorea-acanthocytosis; neuroferritinopathy; spinocerebellar ataxia type 2

Mesh:

Year:  2013        PMID: 24102565     DOI: 10.1111/cge.12283

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

2.  Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.

Authors:  Amanda Krause; Claire Mitchell; Fahmida Essop; Susan Tager; James Temlett; Giovanni Stevanin; Christopher Ross; Dobrila Rudnicki; Russell Margolis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-06-16       Impact factor: 3.568

3.  NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2.

Authors:  Thais L Monte; Estela R Reckziegel; Marina C Augustin; Amanda S P Silva; Lucas D Locks-Coelho; Orlando Barsottini; José L Pedroso; Fernando R Vargas; Maria-Luiza Saraiva-Pereira; Vanessa Bielefeldt Leotti; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2017-08       Impact factor: 3.847

4.  Sex-specific hippocampal 5-hydroxymethylcytosine is disrupted in response to acute stress.

Authors:  Ligia A Papale; Sisi Li; Andy Madrid; Qi Zhang; Li Chen; Pankaj Chopra; Peng Jin; Sündüz Keleş; Reid S Alisch
Journal:  Neurobiol Dis       Date:  2016-08-26       Impact factor: 5.996

5.  Dentatorubro-Pallidoluysian Atrophy (DRPLA) among 700 Families with Ataxia in Brazil.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Gabriel Vasata Furtado; Tailise Conte Gheno; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Orlando G P Barsottini
Journal:  Cerebellum       Date:  2017-08       Impact factor: 3.847

Review 6.  Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes.

Authors:  Ruth H Walker
Journal:  J Mov Disord       Date:  2015-05-31

Review 7.  Evaluating the current state of the art of Huntington disease research: a scientometric analysis.

Authors:  L A Barboza; N C Ghisi
Journal:  Braz J Med Biol Res       Date:  2018-01-11       Impact factor: 2.590

8.  Information and Diagnosis Networks - tools to improve diagnosis and treatment for patients with rare genetic diseases.

Authors:  Taiane Alves Vieira; Franciele Barbosa Trapp; Carolina Fischinger Moura de Souza; Lavínia Schuler Faccini; Laura Bannach Jardim; Ida Vanessa Doederlein Schwartz; Mariluce Riegel; Carmen Regla Vargas; Maira Graeff Burin; Sandra Leistner-Segal; Patrícia Ashton-Prolla; Roberto Giugliani
Journal:  Genet Mol Biol       Date:  2019-06-10       Impact factor: 1.771

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.